NEXGEL, INC. Amortization of Debt Discount (Premium)
NEXGEL, INC. (NXGL) reported Amortization of Debt Discount (Premium) of $1.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-17
- NEXGEL, INC. amortization of debt discount (premium) for the quarter ending 2026-06-30 was $1.90M.
- NEXGEL, INC. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $11.00K.
- NEXGEL, INC. amortization of debt discount (premium) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- NEXGEL, INC. amortization of debt discount (premium) for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- NEXGEL, INC. amortization of debt discount (premium) for fiscal 2021 was $68.00K, a 3300.00% increase from fiscal 2020.
- NEXGEL, INC. amortization of debt discount (premium) for fiscal 2020 was $2.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $1.91M 10-Q · filed 2026-08-17 | ||
| 2026-03-31 | $11.00K 10-Q · filed 2026-05-14 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | $52.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $52.00K derived: sum of 3 quarters · filed 2022-08-10 | $68.00K 10-K · filed 2022-03-21 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $52.00K derived: sum of 2 quarters · filed 2022-08-10 | $68.00K 10-Q · filed 2022-11-08 | $71.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-06-30 | $52.00K 10-Q · filed 2022-08-10 | $68.00K 10-Q · filed 2022-08-10 | $71.00K derived: sum of 3 quarters · filed 2022-08-10 | $71.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-13 | $19.00K derived: sum of 2 quarters · filed 2022-05-13 | $19.00K derived: sum of 3 quarters · filed 2022-05-13 | $19.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $2.00K derived: sum of 2 quarters · filed 2022-03-21 | $2.00K derived: sum of 3 quarters · filed 2022-03-21 | $2.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |